Filing Details
- Accession Number:
- 0001493152-23-031612
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-05 13:21:26
- Reporting Period:
- 2023-08-31
- Accepted Time:
- 2023-09-05 13:21:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1725430 | Intelligent Bio Solutions Inc. | INBS | Surgical & Medical Instruments & Apparatus (3841) | 821512711 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1831767 | Harry Simeonidis | C/O Intelligent Bio Solutions Inc. 142 West 57Th Street, I Ith Floor New York NY 10019 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2023-08-31 | 100 | $1.92 | 4,130 | No | 4 | P | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2023-09-01 | 50 | $1.85 | 4,180 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- On February 9, 2023, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Split"). Unless otherwise noted, the amount of securities and purchase prices reported on this Form 4 have been adjusted to reflect the Reverse Split.